Loading...
•
Jun 30, 2021
Penumbra Q2 2021 Earnings Report
Penumbra's revenue increased significantly, driven by strong growth in both vascular and neuro products, resulting in a return to operating income.
Key Takeaways
Penumbra, Inc. reported a strong second quarter with a 75.3% increase in revenue compared to the previous year, reaching $184.3 million. The company achieved an operating income of $10.3 million, a significant improvement from the operating loss in the same quarter of the previous year. The company is increasing its guidance for 2021 total revenue to be in the range of $720 million to $730 million.
Total revenue increased by 75.3% to $184.3 million compared to Q2 2020.
Vascular product revenue grew by 117.6% to $100.7 million.
Neuro product revenue increased by 42.0% to $83.6 million.
Operating income was $10.3 million, a significant improvement from the $17.6 million operating loss in Q2 2020.
Penumbra
Penumbra
Penumbra Revenue by Geographic Location
Revenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company is increasing its guidance for 2021 total revenue to be in the range of $720 million to $730 million, which represents 28% to 30% growth over 2020 revenue of $560.4 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income